Neuroscientific Biopharmaceuticals Ltd. documents
Data partner
Description
Reported date
Form
2025
Investor Presentation
Aug 18, 2025
Slides
Q4 2025
Jul 22, 2025
Interim report
M&A Announcement
Jun 30, 2025
Press release
Slides
Q3 2025 TU
Apr 23, 2025
Earnings release
H1 2025
Feb 25, 2025
Interim report
Q2 2025 TU
Jan 28, 2025
Earnings release
Q1 2025 TU
Oct 27, 2024
Earnings release
2024
H2 2024
Aug 29, 2024
Annual report
Q4 2024 TU
Jul 19, 2024
Earnings release
Q3 2024 TU
Apr 29, 2024
Earnings release
H1 2024
Feb 27, 2024
Interim report
Q2 2024 TU
Jan 30, 2024
Earnings release
Q1 2024 TU
Oct 30, 2023
Earnings release
2023
Investor Presentation
Oct 31, 2023
Slides
H2 2023
Aug 25, 2023
Annual report
Q4 2023 TU
Jul 28, 2023
Earnings release
Q3 2023 TU
Apr 28, 2023
Earnings release
H1 2023
Feb 27, 2023
Interim report
Investor Presentation
Feb 03, 2023
Slides
Q2 2023 TU
Jan 31, 2023
Earnings release
Q1 2023 TU
Oct 30, 2022
Earnings release
2022
Investor Presentation
Sep 20, 2022
Slides
H2 2022
Aug 29, 2022
Annual report
Q4 2022 TU
Jul 29, 2022
Earnings release
Q3 2022 TU
Apr 29, 2022
Earnings release
Corporate Presentation
Mar 24, 2022
Slides
H1 2022
Feb 27, 2022
Interim report
Q2 2022 TU
Jan 31, 2022
Earnings release
Q1 2022 TU
Oct 29, 2021
Earnings release
2021
Investor Presentation
Dec 02, 2021
Slides
Investor Presentation
Nov 18, 2021
Slides
Corporate Presentation
Oct 26, 2021
Slides
Corporate Presentation
Sep 03, 2021
Slides
H2 2021
Aug 27, 2021
Annual report
Q4 2021 TU
Jul 30, 2021
Earnings release
Q3 2021 TU
Apr 30, 2021
Earnings release
H1 2021
Feb 23, 2021
Interim report
Q2 2021 TU
Jan 29, 2021
Earnings release
Q1 2021 TU
Oct 30, 2020
Earnings release